High Flow Nasal Cannula Oxygen Therapy in Long Hauler Covid-19 Patients

Sarinti Sarinti(1*), Fefi Eka Wahyuningsih(2)


(1) Universitas Muhammadiyah Semarang; Intesive Care Unit, Tugurejo Hospital of Central Java Province
(2) Intesive Care Unit, Tugurejo Hospital of Central Java Province; Department of Nursing, Alkautsar Nursing Academy
(*) Corresponding Author

Abstract


Long Hauler Covid-19 is a condition that describes a person who has recovered from Covid-19 and is declared with a negative PCR smear 2 times but still feels signs and symptoms for a longer period of time, even severe and critical symptoms. Most cases complicate Acute Respiratory Disorder Syndrome (ARDS), which can lead to death. Fulfilment of non-invasive high concentration oxygenation requirements as an intervention modality in this case. The purpose of this case study was to determine the effect of giving oxygen therapy through the High Flow Nasal Cannula (HFNC) on the respiratory function of Covid-19 long haulier patients. The method of nursing care was a case study on 2 respondents with a descriptive approach method. There were 2 cases of Long haulier Covid-19 patients with comorbid smokers, Diabetes Mellitus, experiencing moderate ARDS complications, desaturation, and tachypnea. Patients received oxygen therapy intervention through HFNC while being treated in the critical care room, and after being given HFNC oxygen therapy for 5 days there was a decrease in respiratory frequency, a change in breathing pattern from shortness of breath to shortness of breath, an increase in oxygen saturation, an increase in the ROX Index, an increase in PO2 and blood pH in normal limit. Nursing care that focuses on respiratory management in covid-19 long haulier patients improves patient outcomes in particular, namely decreased respiratory rate, changes in the respiratory pattern of shortness of breath, increased oxygen saturation, increased ROX index, increased PO2 and blood pH within normal limits.

Keywords


Long Hauler Covid-19; ARDS; High Flow Nasal Canule; Critical Care

Full Text:

PDF

References


Baig AMJJomv. Chronic COVID Syndrome: Need for an appropriate medical terminology for Long‐COVID and COVID Long‐Haulers. 2020. DOI: 10.1002/jmv.26624.

Mahase EJb. Covid-19: What do we know about “long covid”? 2020; 370. DOI: https://doi.org/10.1136/bmj.m2815.

Carfì A, Bernabei R and Landi FJJ. Persistent symptoms in patients after acute COVID-19. 2020; 324: 603-605. DOI: 10.1001/jama.2020.12603.

Li LQ, Huang T, Wang Yq, et al. COVID‐19 patients clinical characteristics, discharge rate, and fatality rate of meta‐analysis. Journal of medical virology 2020; 92: 577-583. DOI: https://doi.org/10.1002/jmv.25757.

Siegelman JNJJ. Reflections of a COVID-19 long hauler. 2020; 324: 2031-2032. DOI: 10.1001/jama.2020.22130.

Calligaro GL, Lalla U, Audley G, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. 2020; 28: 100570. DOI: https://doi.org/10.1016/j.eclinm.2020.100570.

Karamouzos V, Fligou F, Gogos C, et al. High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report. 2020; 90. DOI: https://doi.org/10.4081/monaldi.2020.1323.

Li J, Fink JB and Ehrmann SJERJ. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. 2020; 55. DOI: 10.1183/13993003.00892-2020.

Nishimura MJJoic. High-flow nasal cannula oxygen therapy in adults. 2015; 3: 1-8. DOI: 10.1186/s40560-015-0084-5.

Vianello A, Arcaro G, Molena B, et al. High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection. 2020; 75: 998-1000. DOI: 10.1136/thoraxjnl-2020-214993.

Herdman TH and Shigemi K. NANDA-I diagnosis keperawatan: definisi dan klasifikasi 2018-2020. Jakarta: EGC, 2018.

PPNI. Standar diagnosis keperawatan Indonesia. 1 ed. Jakarta: Dewan Pengurus Pusat Persatuan Perawat Nasional Indonesia, 2017.

Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. 2020. DOI: https://doi.org/10.1101/2020.12.24.20248802.

Roncon L, Zuin M, Rigatelli G, et al. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. 2020; 127: 104354. DOI: https://doi.org/10.1016/j.jcv.2020.104354.

Kumar A, Arora A, Sharma P, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. 2020; 14: 535-545. DOI: https://doi.org/10.1016/j.dsx.2020.04.044.

Procopio G, Cancelliere A, Trecarichi EM, et al. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. 2020; 14: 1753466620963016. DOI: https://doi.org/10.1177/1753466620963016.

Hu M, Zhou Q, Zheng R, et al. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study. 2020; 20: 1-7.

Panadero C, Abad-Fernández A, Rio-Ramirez MT, et al. High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19. 2020; 15. DOI: 10.4081/mrm.2020.693.

Suffredini DA and Allison MGJJoICM. A Rationale for Use of High Flow Nasal Cannula for Select Patients With Suspected or Confirmed Severe Acute Respiratory Syndrome Coronavirus-2 Infection. 2021; 36: 9-17. DOI: https://doi.org/10.1177/0885066620956630.

Xu J, Yang X, Huang C, et al. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. 2020; 7: 912. DOI: https://doi.org/10.3389/fmed.2020.607821.


Article Metrics

Abstract view : 1068 times
PDF - 125 times

DOI: https://doi.org/10.26714/seanr.3.1.2021.33-39

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Sarinti Sarinti, Fefi Eka Wahyuningsih

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

View My Stats

Universitas Muhammadiyah Semarang

Kedungmundu Raya Street No. 18 Semarang, NRC Building Universitas Muhammadiyah Semarang

Phone: 02476740287
Fax: 02476740287
Email: [email protected]